Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid

Archives of Internal Medicine

Volumn 156, Issue 12, 1996, Pages 1327-1332

  Garcia Rodriguez, Luis A ^a,e   Stricker, Bruno H ^b,c   Zimmerman, Hyman J ^d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c Netherlands Ctr Monitoring A   (Netherlands)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^e Department of Pharmacoepidemiology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAMAZEPINE; CLAVULANIC ACID; ERYTHROMYCIN ETHYLSUCCINATE; FLUCLOXACILLIN; IMIPRAMINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; QUININE; TRIMETHOPRIM; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOLESTATIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MIXTURE; FEMALE; HUMAN; LIVER INJURY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD; CLAVULANIC ACID; CLAVULANIC ACIDS; COHORT STUDIES; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LIVER DISEASES; MALE; MIDDLE AGED; PENICILLINS; RETROSPECTIVE STUDIES; RISK;

EID: 15844419903     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.12.1327     Document Type: Article

References (28)

1. Trevisani F, Pancione L, Bernardi M, Mazzeti M, Gasbarrini G. Beta-lactam antibiotic-induced cholestatic synergistic effect of phenobarbitone plus corticosteroid treatment, Ital J Gastroenterol. 1988;20:134-136.
2. Anderson CS, Nicholls J, Rowland R, Labrooy JT. Hepatic granulomas: a 15-year experience in the Royal Adelaide Hospital. Med J Aust. 1988;148:71-74.
3. Medicine Control Agency. Cholestatic jaundice with co-amoxiclav. Curr Probl Pharmacovig. 1993;19:2.
4. Van den Broek JW, Buennemeyer BL, Stricker BH. Cholestatic hepatitis due to amoxicillin and clavulanic acid (Augmentin). Ned Tijdschr Geneeskd. 1988; 132:1495-1497.
5. Stricker BH, Van den Broek JW, Keuning J, et al. Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin). Dig Dis Sci. 1989;34:1576-1580.
6. Reddy KR, Brillant P, Schiff ER. Amoxicillin-clavulanate potassium-associated cholestasis. Gastroenterology. 1989;96:1135-1141.
7. Wong FS, Ryan J, Dabkowski P, et al. Augmentin-induced jaundice. Med J Aust. 1991;154:698-701.
8. Adverse Drug Reactions Advisory Committee. Augmentin jaundice. Aust Adverse Drug Reactions Bull. November 1990:2.
9. Ragg M. MaLam and Augmentin. Lancet. 1993;2:487.
10. Pérez Gutthann S, García Rodríguez LA. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology. 1993;4:496-501.
11. Derby LE, Jick H, Henry DA, Dean AD. Cholestatic hepatitis associated with flucloxacillin. Med J Aust. 1993;158:596-600.
12. Derby LE, Jick H, Henry DA, Dean AD. Erythromycin-associated Cholestatic hepatitis. Med J Aust. 1993;158:600-602.
13. Carson JL, Strom BL, Duff A, et al. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med. 1993;119:576-583.
14. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ. 1991; 302:766-768.
15. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Safety. 1992;1:347-349.
16. Benichou C. Criteria of drug-induced liver disorders. J Hepatol. 1990;11:272-276.
17. Martin D, Austin H. An efficient program for computing conditional maximum likelihood and exact confidence limits for a common odds ratio. Epidemiology. 1991;2:359-362.
18. Stricker BH, ed. Drug-Induced Hepatic Injury. Amsterdam, the Netherlands: Elsevier Science Publishers; 1992.
19. Schneider JE, Kleinman MS, Kupic JW. Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium. N Y State J Med. 1989;6:355-356.
20. Verhamme M, Ramboer C, Van de Bruaene P, Inderadjaja N. Cholestatic hepatitis due to an amoxicillin/clavulanic acid preparation. J Hepatol. 1989;9:260-264.
21. Dowsett JF, Gillow T, Heagerty A, et al. Amoxicillin/clavulanic acid (Augmentin) -induced intrahepatic cholestasis. Dig Dis Sci. 1989;34:1290-1293.
22. Escallier F, Dalac S, Caillot D, et al. Erythème polymorhe, aplasie, hépatite cholestatique au cours d'un traitement par Augmentin (amoxicilline+acide clavulanique). Rev Med Interne. 1990;11:73.
23. Hebbard GS, Smith KG, Gibson PR, Bhathal PS. Augmentin-induced jaundice with a fatal outcome. Med J Aust. 1992;156:285-286.
24. Larrey D, Vial T, Micaleff A, et al. Hepatitis associated with amoxicillin-clavulanic acid combination report of 15 cases. Gut. 1992;33:368-371.
25. Cleau D, Jobard JM, Alves T, et al. Hépatite cholestatique de à l'association amoxicilline-acide clavulanique: un cas et revue de la littérature. Gastroenterol Clin Biol. 1990;14:1007-1009.
26. Rodríguez M, Sleiman H, Suarez A, Rodrigo L. Hepatitis cotestásica por amoxicilina-acido clavulánico. Med Clin. 1991;96:78.
27. Silvain C, Fort E, Levillain P, Labat-Labourdette J, Beauchant M. Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid. Dig Dis Sci. 1992;37:150-152.
28. Zimmerman HJ. Jaundice due to bacterial infection. Gastroenterology. 1979; 77:362-374.